A research cooperation of the Paracelsus Medical University Salzburg and the Paris Lodron University Salzburg co-founded a „Transfer Center for Extracellular Vesicles – Theralytic Technologies“ (EV-TT) to conduct fundamental and applied biomedical research and development with a focus on revolutionary and innovative, regenerative medicine and drug delivery approaches using extracellular vesicles. The project has a total volume of € 3.6 million and received funding from Land Salzburg/IWB/EFRE 2014-2020 and Land Salzburg/WISS 2025 over a period of four years. The new research entity appointed Torsten Hoffmann, SVP Drug Discovery at Taros to chair the Scientific Advisory Board. [see homepage]

International Online Press Reactions:

• Portal der Wirtschaft "Taros Chemicals’ SVP Dr. Torsten Hoffmann appointed as chairman to EV-TT’s Scientific Advisory Board"  [see homepage]